Yuflyma

Licence status
Authorised: 16/02/2022
Active substances
Adalimumab
Dosage Form
Solution for injection
Licence number
EU/1/20/1513/013-016
Licence holder
Celltrion Healthcare Hungary Kft.

Product documents

Licence information

ATC code
L04AB04 adalimumab
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
16/02/2022